equityflowunderstand the flow and follow it

Timeline

Biotech · Lausanne, CH

Longevity and healthy-ageing biotech (Mitopure).

Founders

Chris Rinsch (United States · ♂) — A biomedical engineer and life-sciences entrepreneur, he co-founded Amazentis as a spin-off of EPFL in 2007 and, after 15 years researching Urolithin A, launched the Timeline cellular-nutrition brand.
Patrick Aebischer (Switzerland · ♂) — A neuroscientist and former president of EPFL, he co-founded Amazentis to translate the university's longevity science into the Mitopure Urolithin A products sold under Timeline.

Date	Round	Amount
Jan 2024	Series D Plus Timeline, a Lausanne longevity biotech, raised a $66M Series D led by L'Oreal's BOLD fund and Nestle.	$66M
Apr 2022	Series A Timeline, a UK retirement financial-planning fintech, raised a GBP6M ($8M) Series A led by MTech Capital, with FNZ participating.	$8M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.